Vistagen Therapeutics (VTGN) Tax Rate (2011 - 2026)

Vistagen Therapeutics (VTGN) posted Tax Rate of 0.04% for Q1 2026, up 20.47% sequentially from 0.05% in Q3 2024.

Vistagen Therapeutics (VTGN) Tax Rate (2011 - 2026) Analysis & Trends

Vistagen Therapeutics has reported Tax Rate for 14 years, with the latest figure at 0.04% in Q1 2026.

Quarterly Tax Rate changed N/A year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2026 annual result came in at 0.01%, changed 0.0% from the prior year.
Tax Rate grew to 0.04% in Q1 2026 per VTGN's latest filing, from 0.05% in the prior quarter.
Over five years, Tax Rate peaked at 0.01% in Q1 2023 and troughed at 0.05% in Q3 2024.
A 4-year average of 0.03% and a median of 0.04% in 2022 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2023: Tax Rate rose 1 bps in 2022, then declined 2 bps in 2023.
Over 4 years, Tax Rate stood at 0.03% in 2022, then sank by 56 bps to 0.04% in 2023, then slipped by 24 bps to 0.05% in 2024, then climbed by 20 bps to 0.04% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.04%, 0.05%, and 0.01% for Q1 2026, Q3 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.96 Bn	132.11 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	86.79 Bn	78.79 Bn	3.93 Bn	15.11%
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn	10.91%
4	Moderna	60.20 Bn	55.06 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	42.19 Bn	37.09 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.43 Bn	28.12 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.65 Bn	10.26 Bn	668.28 Mn	34.12%
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.16 Bn	26.32 Bn	-	-
10	Vistagen Therapeutics	10.41 Mn	10.41 Mn	-	-

Download Data